These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38194770)

  • 21. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial.
    Patel AD; Mazurkiewicz-Bełdzińska M; Chin RF; Gil-Nagel A; Gunning B; Halford JJ; Mitchell W; Scott Perry M; Thiele EA; Weinstock A; Dunayevich E; Checketts D; Devinsky O
    Epilepsia; 2021 Sep; 62(9):2228-2239. PubMed ID: 34287833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis.
    Tabaee Damavandi P; Fabin N; Giossi R; Matricardi S; Del Giovane C; Striano P; Meletti S; Brigo F; Trinka E; Lattanzi S
    Neurol Ther; 2023 Apr; 12(2):669-686. PubMed ID: 36853503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta-analysis.
    Zhang L; Li W; Wang C
    Acta Neurol Scand; 2021 Apr; 143(4):339-348. PubMed ID: 33336426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real-world study.
    Gjerulfsen CE; Nikanorova M; Olofsson K; Johannessen Landmark C; Rubboli G; Møller RS
    Epilepsia Open; 2024 Oct; 9(5):1891-1900. PubMed ID: 39140199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
    Lattanzi S; Brigo F; Trinka E; Zaccara G; Cagnetti C; Del Giovane C; Silvestrini M
    Drugs; 2018 Nov; 78(17):1791-1804. PubMed ID: 30390221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    García-Peñas JJ; Gil Nagel-Rein A; Sánchez-Carpintero R; Villanueva-Haba V
    Rev Neurol; 2021 Sep; 73(S01):S1-S8. PubMed ID: 34486101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
    Silvinato A; Floriano I; Bernardo WM
    Rev Assoc Med Bras (1992); 2022; 68(10):1345-1357. PubMed ID: 36417631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome.
    Lagae L; Schoonjans AS; Gammaitoni AR; Galer BS; Ceulemans B
    Epilepsia; 2018 Oct; 59(10):1881-1888. PubMed ID: 30146701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
    Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
    Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Wijnen B; Armstrong N; Ramaekers B; Witlox W; Westwood M; Fayter D; Ryder S; Buksnys T; Worthy G; Misso K; Grimm S; Kleijnen J; Joore M
    Pharmacoeconomics; 2020 Oct; 38(10):1043-1053. PubMed ID: 32514751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
    Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
    Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
    CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study.
    Specchio N; Pietrafusa N; Doccini V; Trivisano M; Darra F; Ragona F; Cossu A; Spolverato S; Battaglia D; Quintiliani M; Luigia Gambardella M; Rosati A; Mei D; Granata T; Dalla Bernardina B; Vigevano F; Guerrini R
    Epilepsia; 2020 Nov; 61(11):2405-2414. PubMed ID: 32945537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenfluramine below the age of 2 years in Dravet syndrome: What about safety and efficacy?
    Pietrafusa N; Trivisano M; Casellato S; Correale C; Cappelletti S; De Liso P; Onida I; Sotgiu S; Butera A; Specchio N; Vigevano F
    Epilepsia; 2024 Feb; 65(2):e7-e13. PubMed ID: 38065833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F; Jones K; Eltze C; Matricardi S
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003277. PubMed ID: 33825230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.
    Balagura G; Cacciatore M; Grasso EA; Striano P; Verrotti A
    CNS Drugs; 2020 Oct; 34(10):1001-1007. PubMed ID: 32875491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder.
    Devinsky O; King L; Schwartz D; Conway E; Price D
    Epilepsia; 2021 Jul; 62(7):e98-e102. PubMed ID: 33979451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.
    Schoonjans A; Paelinck BP; Marchau F; Gunning B; Gammaitoni A; Galer BS; Lagae L; Ceulemans B
    Eur J Neurol; 2017 Feb; 24(2):309-314. PubMed ID: 27790834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment.
    Bishop KI; Isquith PK; Gioia GA; Knupp KG; Scheffer IE; Nabbout R; Specchio N; Sullivan J; Auvin S; Helen Cross J; Guerrini R; Farfel G; Galer BS; Gammaitoni AR
    Epilepsy Behav; 2023 Jan; 138():108994. PubMed ID: 36463826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.